Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Brazilian (BOVESPA) Biotech Industry Analysis

UpdatedDec 06, 2024
DataAggregated Company Financials
Companies2
  • 7D6.2%
  • 3M-6.0%
  • 1Y-1.9%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 8.8%, driven by pullbacks from every company within the industry. The industry has fallen 6.2% in the last year. Looking forward, earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the Brazilian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 07 Dec 2024R$3.4bR$1.8bR$114.3m13.3x29.3x1.9x
Mon, 04 Nov 2024R$3.7bR$1.7bR$139.3m12x26.7x2.2x
Wed, 02 Oct 2024R$3.6bR$1.7bR$139.3m10.7x25.6x2.1x
Fri, 30 Aug 2024R$3.5bR$1.7bR$139.3m10.8x24.8x2x
Sun, 28 Jul 2024R$3.4bR$1.6bR$157.7m8.4x21.4x2.1x
Tue, 25 Jun 2024R$3.5bR$1.6bR$157.7m7.3x22.3x2.2x
Thu, 23 May 2024R$3.2bR$1.6bR$157.7m7.9x20.4x2x
Sat, 20 Apr 2024R$3.3bR$1.5bR$168.7m7.3x19.4x2.2x
Mon, 18 Mar 2024R$3.3bR$1.5bR$234.7m6.7x13.9x2.2x
Wed, 14 Feb 2024R$2.8bR$1.5bR$234.7m6.7x11.9x1.9x
Fri, 12 Jan 2024R$3.2bR$1.5bR$234.7m8.7x13.5x2.2x
Sun, 10 Dec 2023R$3.4bR$1.5bR$234.7m9.2x14.5x2.3x
Tue, 07 Nov 2023R$3.4bR$1.5bR$226.7m9.5x14.9x2.3x
Thu, 05 Oct 2023R$3.2bR$1.5bR$226.7m9.3x14.2x2.2x
Sat, 02 Sep 2023R$3.6bR$1.5bR$226.7m10x15.7x2.4x
Mon, 31 Jul 2023R$4.2bR$1.5bR$264.3m10.3x15.8x2.8x
Wed, 28 Jun 2023R$3.9bR$1.5bR$264.3m9.7x14.8x2.7x
Fri, 26 May 2023R$4.2bR$1.5bR$264.3m10.7x16x2.9x
Sun, 23 Apr 2023R$3.8bR$1.5bR$270.8m9.8x14.2x2.5x
Tue, 21 Mar 2023R$5.4bR$1.5bR$262.5m13.7x20.5x3.6x
Thu, 16 Feb 2023R$5.6bR$1.5bR$212.7m16.4x26.1x3.7x
Sat, 14 Jan 2023R$5.3bR$1.5bR$212.7m15.4x25.1x3.6x
Mon, 12 Dec 2022R$4.9bR$1.5bR$212.7m14.3x23.1x3.3x
Wed, 09 Nov 2022R$6.4bR$1.5bR$221.2m18.8x28.9x4.3x
Fri, 07 Oct 2022R$6.3bR$1.5bR$221.1m18.2x28.3x4.3x
Sun, 04 Sep 2022R$6.4bR$1.5bR$221.1m18.4x28.7x4.4x
Tue, 02 Aug 2022R$5.6bR$1.5bR$218.8m16.9x25.7x3.8x
Thu, 30 Jun 2022R$4.9bR$1.5bR$218.8m14.2x22.3x3.3x
Sat, 28 May 2022R$5.2bR$1.5bR$218.8m14.7x23.7x3.5x
Mon, 25 Apr 2022R$5.5bR$1.5bR$245.0m14.4x22.4x3.7x
Wed, 23 Mar 2022R$6.0bR$1.5bR$250.9m15.7x23.8x4.1x
Fri, 18 Feb 2022R$6.9bR$1.5bR$279.4m16.8x24.7x4.7x
Sun, 16 Jan 2022R$6.5bR$1.5bR$279.4m15.8x23.3x4.5x
Tue, 14 Dec 2021R$7.9bR$1.5bR$279.4m19.7x28.3x5.4x
Price to Earnings Ratio

28.3x


Total Market Cap: R$7.9bTotal Earnings: R$279.4mTotal Revenue: R$1.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Biotech Industry Price to Earnings3Y Average 20.7x202220232024
Current Industry PE
    There are only 2 companies in the Brazilian Biotechnology industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have declined 26% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.4% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Brazilian Biotech compare with similar industries?

BR Market2.67%
Healthcare-0.33%
Biotech6.22%
Biotech6.22%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BLAU3 Blau FarmacêuticaR$13.672.1%
+R$49.8m		-16.4%PE13x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BLAU3

R$13.67

Blau Farmacêutica

7D

2.1%

1Y

-16.4%

Does Blau Farmacêutica (BVMF:BLAU3) Have A Healthy Balance Sheet?

Dec 04
Does Blau Farmacêutica (BVMF:BLAU3) Have A Healthy Balance Sheet?

BIOM3

R$8.10

Biomm

7D

-0.1%

1Y

30.9%